Blood Pressure Treatment by the Corsano CardioWatch 287-2 Evaluation Study

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 2, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions
High Blood Pressure
Interventions
DEVICE

Corsano CardioWatch 287-2 non-invasive blood pressure (NIBP) monitoring

Patients receive Corsano CardioWatch 287-2 for continous NIBP monitoring and perform several spot-checks using an automated BP cuff as a reference during the start or uptitration of BP lowering medication

Trial Locations (1)

2625 AD

RECRUITING

Reinier de Graaf Gasthuis, Delft

Sponsors
All Listed Sponsors
lead

Corsano Health B.V.

INDUSTRY

NCT06508619 - Blood Pressure Treatment by the Corsano CardioWatch 287-2 Evaluation Study | Biotech Hunter | Biotech Hunter